Results 171 to 180 of about 2,894,735 (305)

Anti-aging effects of glycyrrhizin via maintaining Klotho levels. [PDF]

J Clin Biochem Nutr
Ohnishi S, Hiramoto K, Yoshikawa N, Kawanishi S.   +3 more
europepmc   +1 more source

Plasma EV Proteomics Identifies ECM Remodeling and Inflammatory Proteins LUM and C7 as Candidate Biomarkers in FSHD

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Facioscapulohumeral muscular dystrophy (FSHD) is one of the most debilitating and common muscular dystrophies. Despite its severity, no approved therapy exists for FSHD patients. However, several therapeutic candidates are currently under development, and some have recently entered clinical trials, marking the need for reliable ...
Mustafa Bilal Bayazit, Chiranth K. Nagaraj, Jackson S. Newell, Kim Truc Nguyen, Xilal Y. Rima, Jacob Doon‐Ralls, Eduardo Reátegui, Jeffrey M. Statland, Rabi Tawil, Kevin M. Flanigan, Scott Q. Harper, Nizar Y. Saad   +11 more
wiley   +1 more source

Other title: Kansas Department for Aging and Disability Services Overview; Other title: Overview

, 2018
application/pdf; "1/11/2018."; Committee name taken from Kansas Department for Aging and Disability Services website.; Presentation before the Kansas Legislature, House Children and Seniors Committee, by the Kansas Department for Aging and Disability ...
Kansas. Department for Aging and Disability Services.
core  

<i>Prosopis cineraria</i> (Ghaf) Extract as a Natural Ingredient for Anti-Aging Dermocosmetic Applications. [PDF]

Antioxidants (Basel)
De Santes B, Morelli L, Spena F, Pagliari S, Huc-Mathis D, Collet G, Daniellou R, Giustra M, Campone L, Cerri F, Galli P, Prosperi D, Salvioni L, Colombo M.   +13 more
europepmc   +1 more source

Onasemnogene Abeparvovec in Patients With SMA: Interim Results of the RESTORE Registry in Japan

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective There are limited real‐world data regarding the safety and effectiveness of onasemnogene abeparvovec (OA; Zolgensma) infusion, a one‐time gene replacement therapy, for Japanese patients with spinal muscular atrophy (SMA). We aimed to improve understanding of the real‐world outcomes for OA in Japan.
Kayoko Saito, Kamal Benguerba, Ken Tsuchida, Kazushige Yazawa, Isao Tsumiyama, Hiromitsu Kayama, Sandra P. Reyna, Farid Khan, Richard S. Finkel   +8 more
wiley   +1 more source

Towards Metabolomics-Guided Healthy and Anti-Aging Nutrition. [PDF]

Metabolites
Lokhov PG, Balashova EE, Maslov DL, Trifonova OP, Lokhov AP, Archakov AI.   +5 more
europepmc   +1 more source

White Matter Microstructural Abnormalities in Neonatal Onset Genetic Epilepsy

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Recent evidence indicates that epilepsy is associated with abnormal white matter. If seizures alter white matter, then the impact upon network function, epileptogenesis, and cognition could be pronounced in neonates undergoing rapid developmental myelination. Neonates with epilepsy due to nonstructural genetic causes provide a unique
Amanda G. Sandoval Karamian, Tianjia Zhu, Hao Huang, Shavonne L. Massey, Mark P. Fitzgerald, Darshana Parikh, Arastoo Vossough, Ingo Helbig, Nicholas S. Abend   +8 more
wiley   +1 more source

Physical exercise therapy as an anti-aging strategy for osteosarcopenia: a narrative review. [PDF]

Front Aging
Liu TT, Zhang P, Dong WT, Gong YL, Fang ZJ, Li N, Ma X.   +6 more
europepmc   +1 more source

Neurochemical Endpoints to Inform Early‐Stage Trials of Spinocerebellar Ataxia 2 and 3 in a Multisite Setting

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Neurochemical levels measured by brain MR spectroscopy (MRS) have been proposed as endpoints for clinical trials in early‐stage spinocerebellar ataxia (SCA) trials. We tested their trial‐readiness by quantifying neurochemicals in three affected brain regions in early‐stage cohorts of SCA2 and SCA3, examining their reproducibility in ...
James M. Joers, Yaqiao Wei, Dinesh K. Deelchand, Adam Berrington, Young Woo Park, Guita Banan, Michal Povazan, Jens T. Rosenberg, André J. W. van der Kouwe, Tetsuo Ashizawa, Khalaf O. Bushara, Chiadi U. Onyike, Sub H. Subramony, Jeremy D. Schmahmann, Brian J. Soher, Peter B. Barker, Thomas H. Mareci, Eva‐Maria Ratai, Lynn E. Eberly, Gülin Öz   +19 more
wiley   +1 more source

Artificial intelligence-driven identification and mechanistic exploration of synergistic anti-aging compounds from Dengzhan Shengmai formulation. [PDF]

PLoS One
Hou J, Li X, Gu M, Ding K, Yang K, Xu B.
europepmc   +1 more source